QS Investors’s CareDx CDNA Stock Holding History

QS Investors’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-12,300	Closed	-$891K	–	1194
2020 Q4	$891K	Hold	12,300	–	–	0.01%	542
2020 Q3	$467K	Sell	12,300 -51,850	-81%	-$1.75M	0.01%	728
2020 Q2	$2.27M	Sell	64,150 -1,000	-2%	-$28.5K	0.03%	438
2020 Q1	$1.42M	Sell	65,150 -150	-0.2%	-$3.36K	0.02%	555
2019 Q4	$1.38M	Sell	65,300 -1,000	-2%	-$22.9K	0.01%	695
2019 Q3	$1.5M	Hold	66,300	–	–	0.02%	653
2019 Q2	$2.39M	Sell	66,300 -1,650	-2%	-$52.8K	0.03%	516
2019 Q1	$2.14M	Hold	67,950	–	–	0.02%	579
2018 Q4	$1.71M	Buy	+67,950	New	+$1.75M	0.02%	606

Other funds holding CDNA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

QS Investors's CDNA Position: Q1 2021 in Review

QS Investors sold out of CareDx (CDNA) in Q1 2021, closing a stake of 12,300 shares — an estimated $891K sold.

QS Investors first reported a position in CDNA in Q4 2018 and held it in 9 quarters. The position peaked at $2.39M in Q2 2019. 245 funds tracked by Wall St. Rank hold CDNA as of Q1 2021.

QS Investors reported no remaining CareDx position as of Q1 2021 after selling out during the quarter.
QS Investors sold 12,300 CareDx shares in Q1 2021, an estimated $891K.
QS Investors first reported a position in CareDx in Q4 2018 and held it in 9 quarters.
QS Investors's CareDx position peaked at $2.39M in Q2 2019.
245 funds tracked by Wall St. Rank held CareDx as of Q1 2021.

Based on QS Investors's 13F filing for Q1 2021, filed 13 May 2021.